Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

WVE stock hub

Wave Life Sciences Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

WVEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

WVE

In the news

Latest news · WVE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-53.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-33.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All WVE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001631574
Company name	Wave Life Sciences Ltd.
Country	Singapore
Country code	US
Cusip	Y95308105
Employees	317
Employees Change	29%
Employees Change Percent	10.07
Enterprise value	$852.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2015-11-11
Isin	SG9999014716
Last refreshed	2026-05-10
Market cap	$1.4B
Market cap category	Small-Cap
Price	$7.18
Price currency	USD
Rev Per Employee	226,492.11x
Sector	Healthcare
Sic	2834
Symbol	WVE
Website	https://wavelifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.29%
EV Sales Forward	26.79x
EV/Sales	11.87x
FCF yield	-13.39%
P/B ratio	2.7x
P/S ratio	19.24x
PS Forward	43.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-274.21%
EBITDA Margin	-269.47%
Gross margin	-164.07%
Gross Profit	$-117.8M
Net Income	$-183.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-255.7%
Profit Margin	-255.7%
Profit Per Employee	$-579,139
ROA	-28.23
Roa5y	-31.91
ROCE	-36.89
ROE	-53.11
Roe5y	-2,338.2
ROIC	-33.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.23%
Cagr1y	10.64%
Cagr3y	21.63%
Cagr5y	3.38%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-31.58x
Revenue Growth Q	316.85x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	69.18x
Revenue Growth5 Y	35.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.16
Assets	$583.5M
Cash	$544.6M
Current Assets	$561.3M
Current Liabilities	$49.8M
Debt	$15.7M
Debt Equity	$0.03
Equity	$511.7M
Liabilities	$71.8M
Long Term Assets	$22.3M
Long Term Liabilities	$22M
Net Cash	$528.9M
Net Cash By Market Cap	$38.29
Net Cash Growth	140.97%
Net Debt Equity	$-1.03
Tangible Book Value	$511.7M
Tangible Book Value Per Share	$2.66
WACC	-2.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.26
Net Working Capital	$-24.8M
Quick ratio	10.93
Working Capital	$511.4M
Working Capital Turnover	$0.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.45%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-52.76%
1Y total return	10.63%
200-day SMA	10.19
3Y total return	79.95%
50-day SMA	9.34
50-day SMA vs 200-day SMA	50under200
5Y total return	18.09%
All Time High	56
All Time High Change	-87.18%
All Time High Date	2018-09-24
All Time Low	1.16
All Time Low Change	518.97%
All Time Low Date	2022-05-13
ATR	0.48
Beta	-1.32
Beta1y	1.06
Beta2y	2.02
Ch YTD	-57.76
High	7.29
High52	21.73
High52 Date	2025-12-09
High52ch	-66.96%
Low	7.1
Low52	5.02
Low52 Date	2026-03-26
Low52ch	43.03%
Ma50ch	-23.16%
Premarket Change Percent	-0.55
Premarket Price	$7.2
Premarket Volume	4,339
Price vs 200-day SMA	-29.5%
RSI	40.24
RSI Monthly	47.09
RSI Weekly	38.45
Sharpe ratio	0.61x
Sortino ratio	1.59
Total Return	-21.45%
Tr YTD	-57.76
Tr1m	1.13%
Tr1w	-1.91%
Tr3m	-46.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	16
Analyst Count Top	4
Analyst Price Target Top	$42.75
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.32
Earnings Revenue Estimate	8,485,376x
Earnings Revenue Estimate Growth	-7.52x
Operating Income	$-196.9M
Operating margin	-274.2
Price target	$28.88
Price Target Change	$302
Price Target Change Top	$495

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	90,472,141%
Float Percent	47.03%
Shares Insiders	0.4%
Shares Institutions	66.03%
Shares Out	192,379,977
Shares Qo Q	11.11%
Shares Yo Y	21.45%
Short Float	14.75%
Short Ratio	2.06
Short Shares	6.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-214.1M
Average Volume	4,097,061.6x
Bv Per Share	2.66
CAPEX	$-991,000
Ch10y	-52.76
Ch1m	1.13
Ch1w	-1.91
Ch1y	10.63
Ch3m	-46.62
Ch3y	79.95
Ch5y	18.09
Ch6m	-8.65
Change	-0.83%
Change From Open	-0.14
Close	7.24
Days Gap	-0.69
Depreciation Amortization	3,406,000
Dollar Volume	18,314,801.4
Earnings Date	2026-04-28
Earnings Time	bmo
EBIT	$-196.9M
EBITDA	$-193.5M
EPS	$-1.03
F Score	1
FCF	$-185M
FCF EV Yield	-21.7x
FCF Per Share	$-0.96
Financing CF	486,607,000
Fiscal Year End	December
Founded	2,012
Investing CF	-991,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	10.85
Ma150ch	-33.79%
Ma20	7.3
Ma20ch	-1.7%
Net CF	301,559,000
Next Earnings Date	2026-07-29
Open	7.19
Optionable	Yes
Position In Range	42.11
Post Close	7.18
Postmarket Change Percent	1.39
Postmarket Price	$7.28
Ppne	18,071,000
Pre Close	7.24
Price Date	2026-05-08
Ptbv Ratio	2.7
Relative Volume	0.62x
Revenue	71,798,000x
SBC By Revenue	40.51x
Share Based Comp	29,083,000
Tr6m	-8.65%
Volume	2,550,808
Z Score	10.22

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does WVE pay a dividend?

Capital-return profile for this ticker.

Performance

WVE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns WVE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+66.0%

Float: +47.0% of shares outstanding

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

WVE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.2

Neutral momentum band

Price vs 200-day MA

-29.5%

50/200-day relationship not available

Beta (5Y)

-1.32

Less volatile than the market

Sharpe ratio

0.61

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About WVE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current WVE stock rating?

Wave Life Sciences Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full WVE analysis?

The full report lives at /stocks/WVE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for WVE?

The latest report frames WVE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the WVE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.